The briefing
Researchers from the University of Gothenburg and Sahlgrenska University Hospital conducted the first randomized trial of cortisone eye drops for serious eye disease in extremely premature babies. The findings suggest the drops may slow disease progression and reduce the risk of blindness, pending further validation.
Original headline
Cortisone eye drops may reduce blindness in extremely premature babies